Parian Global Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$254K Sell
88,978
-292,518
-77% -$1.24M 0.83% 22
2022
Q2
$1.9M Sell
381,496
-17,906
-4% -$93.8K 8.68% 5
2022
Q1
$2.84M Sell
399,402
-2,085
-0.5% -$17.2K 5.85% 8
2021
Q4
$7.3M Buy
401,487
+67,465
+20% +$1.46M 5.86% 4
2021
Q3
$6.53M Buy
334,022
+182,017
+120% +$6.92M 4.56% 8
2021
Q2
$6.81M Buy
+152,005
New +$7.05M 2.92% 13
2021
Q1
Sell
-82,839
Closed -$7.41M 67
2020
Q4
$7.41M Buy
+82,839
New +$6.97M 1.85% 19

Other funds holding CELL

Parian Global Management's CELL Position: Q3 2022 in Review

Parian Global Management reduced its PhenomeX Inc. Common Stock (CELL) stake by 77% in Q3 2022, selling an estimated $1.24M and leaving 88,978 shares worth $254K. The position accounts for 0.83% of the portfolio, ranked #22.

Parian Global Management first reported a position in CELL in Q4 2020 and has held it in 7 quarters since. The position peaked at $7.41M in Q4 2020. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Parian Global Management held 88,978 shares of PhenomeX Inc. Common Stock worth $254K as of Q3 2022.
  • Parian Global Management sold 292,518 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $1.24M.
  • PhenomeX Inc. Common Stock made up 0.83% of Parian Global Management's portfolio in Q3 2022, its #22 holding.
  • Parian Global Management first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and has held it in 7 quarters since.
  • Parian Global Management's PhenomeX Inc. Common Stock position peaked at $7.41M in Q4 2020.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.